Localized Prostate Cancer Treated with Intensity-Modulated Radiotherapy

Zelefsky M.J. , Leibel S.A. , Gaudin P.B. , Kutcher G.J. , Fleshner N.E. , Venkatramen E.S. , Reuter V.E. , Fair W.R. , Ling C.C. , Fuks Z. : Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys, 41: 491–500, 1998.

Hanks G.E. , Hanlon A.L. , Pinover W.H. , Horwitz E.M. , Price R.A. , Schultheiss T. : Dose selection for prostate cancer based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys, 46: 823–832, 2000.

Magrini S.M. , Cellai E. , Pertici M. , Rossi F. , Ponticelli P. , Odantini R. , Cappellini M. , Biti G.P. : Radical radiotherapy of localised prostate cancer: the relationship between radiation dose and survival. Cancer Radiother, 2: 351–358, 1998.

Zelefsky M.J. , Fuks Z. , Hunt M. , Lee H.J. , Lombardi D. , Ling C.C. , Reuter V.E. , Venkatraman E.S. , Leibel S.A. : High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol, 166: 1839, 2001.

Corn B.W. , Hanks G.E. , Schultheiss T.E. , Hunt M.A. , Lee W.R. , Coia L.R. : Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment. Int J Radiat Oncol Biol Phys, 32: 325–330, 1995.

Lee W.R. , Hanks G.E. , Schultheiss T.E. , Corn B.W. , Hunt M.A. : Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen-driven outcome analysis. J Clin Oncol, 13: 464–469, 1995.

Lawton C.A. , Won M. , Pilepich M.V. , Asbell S.O. , Shipley W.U. , Hanks G.E. , Cox J.D. , Perez C.A. , Sause W.T. , Doggett S.R. : Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys, 21: 935–939, 1991.

Michalski J.M. , Purdy J.A. , Winter K. , Roach M. , Vijayakumar S. , Sandler H.M. , Markoe A.M. , Ritter M.A. , Russell K.J. , Sailer S. , Harms W.B. , Perez C.A. , Wilder R.B. , Hanks G.E. , Cox J.D. : Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys, 46: 391–402, 2000.

Foppiano F. , Fiorino C. , Frezza G. , Greco C. , Valdagni R. , AIRO National Working Group on Prostate Radiotherapy: The impact of contouring uncertainty on rectal 3D dose-volume data: results of a dummy run in a multicenter trial (AIRO-PROS01-02). Int J Radiat Oncol Biol Phys, 57: 573–579, 2003.

Michalski J.M. , Winter K. , Purdy J.A. , Wilder R.B. , Perez C.A. , Roach M. , Parliament M.B. , Pollack A. , Markoe A.M. , Harms W. , Sandler H.M. , Cox J.D. : Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. Int J Radiat Oncol Biol Phys, 56: 192–198, 2003.

Boehmer D. , Bohsung J. , Eichwurzel I. , Moys A. , Budach V. : Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer. Radiother Oncol, 71: 319–325, 2004.

Kuban D. , Pollack A. , Huang E. , Levy L. , Dong L. , Starkschall G. , Rosen I. : Hazards of dose escalation in prostate Cancer radiotherapy. Int J Radiat Oncol Biol Phys, 57: 1260–1268, 2003.

Huang E.H. , Pollack A. , Levy L. , Starkschall G. , Dong L. , Rosen I. , Kuban D.A. : Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys, 54: 1314–1321, 2002.

Fiorino C. , Sanguineti G. , Cozzarini C. , Fellin G. , Foppiano F. , Menegotti L. , Piazzolla A. , Vavassori V. , Valdagni R. : Rectal dose–volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys, 57: 953–962, 2003.

Bucciolini M. , Banci Buonamici F. , Casati M. : Verification of IMRT fields by film dosimetry. Med Phys, 31: 161–168, 2004.

Emani B. , Lyman J. , Brown A. , Coia L. , Goitein M. , Munzerider J.E. , Shank B. , Solin L.J. , Wesson M. : Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys, 21: 109–122, 1991.

Lyman J.T. : Complication probability as assessed from dose-volume histograms. Radiat Res Suppl, 104: 13–19, 1985.

Kutcher G.J. , Burman C. : Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys, 16: 1623–1630, 1989.

Burman C. , Kutcher G J. , Emami B. , Goitein M. : Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys, 21: 123–135, 1991.

Nutting C.M. , Corbishley C.M. , Sanchez-Nieto B. , Cosgrove V.P. , Webb S. , Dearnaley D.P. : Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. Br J Radiol, 75: 151–161, 2002.

Teh B.S. , Woo S.Y. , Butler E.B. : Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology. Oncologist, 4: 433–442, 1999.

De Meerleer G. , Vakaet L. , Meersschout S. , Villeirs G. , Verbaeys A. , Oosterlinck W. , De Neve W. : Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. Int J Radiat Oncol Biol Phys, 60: 777–787, 2004.

Zelefsky M.J. , Fuks Z. , Happersett L. , Lee H.J. , Ling C.C. , Bur-man C.M. , Hunt M. , Wolfe T. , Venkatraman E.S. , Jackson A. , Skwarchuk M. , Leibel S.A. : Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol, 55: 241–249, 2000.

Peeters S.T. , Heemsbergen W.D. , van Putten W.L. , Slot A. , Tabak H. , Mens J.W. , Lebesque J.V. , Koper P.C. : Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys, 61: 1019–1034, 2005.

Zelefsky M.J. , Fuks Z. , Hunt M. , Yamada Y. , Marion C. , Ling C.C. , Amols H. , Venkatraman E.S. , Leibel S.A. : High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys, 53: 1111–1116, 2002.

Leibel S.A. , Zelefsky M.J. , Kutcher G.J. , Burman C.M. , Kelson S. , Fuks Z. : Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase-1 dose-escalation study. J Urol, 152: 1792–1798, 1994.

Magrini S.M. , Bertoni F. , Vavassori V. , Villa S. , Cagna E. , Maranzano E. , Pertici M. , Pradella R. , Spediacci M.A. , Chiavacci A. , Ambrosi E. , Livi L. , Magli A. , Bellavita R. , Bossi A. , Biti G. : Practice patterns for prostate cancer in nine central and northern Italy radiation oncology centers: a survey including 1759 patients treated during two decades (1980–1998). Int J Radiat Oncol Biol Phys, 52: 1310–1319, 2002.

Cheung R. , Tucker S.L. , Lee A.K. , de Crevoisier R. , Dong L. , Kamat A. , Pisters L. , Kuban D. : Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys, 61: 993–1002, 2005.

Lyons J.A. , Kupelian P.A. , Mohan D.S. , Reddy C.A. , Klein E.A. : Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1–T3 adenocarcinoma of the prostate. Urology, 55: 85, 2000.

Pollack A. , Zagars G.K. : External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys, 39: 1011–1018, 1997.

Pollack A. , Zagars G.K. , Smith L.G. , Lee J.J. , von Eschenbach A.C. , Antolak J.A. , Starkschall G. , Rosen I. : Preliminary results of a randomized radiotherapy dose escalation study comparing 70 Gy to 78 Gy for prostate cancer. J Clin Oncol, 18: 3904, 2000.